Antineoplastons - Articles - Scientific Research Publishing

A Phase II Study of Antineoplastons A10 and AS2-1 in Children with High-Grade Glioma. Final Report (Protocol BT-06), and Review of Recent Trials (Articles)

Stanislaw R. Burzynski, Tomasz J. Janicki, Gregory S. Burzynski, Ania Marszalek

Journal of Cancer Therapy Vol.5 No.6, May 26, 2014

DOI: 10.4236/jct.2014.56065 5,047 Downloads 7,587 Views Citations
The Effect of Antineoplastons A10 and AS2-1 and Metabolites of Sodium Phenylbutyrate on Gene Expression in Glioblastoma Multiforme (Articles)

Stanislaw R. Burzynski, Sonali S. Patil

Journal of Cancer Therapy Vol.5 No.10, September 4, 2014

DOI: 10.4236/jct.2014.510099 5,310 Downloads 7,725 Views Citations
This article belongs to the Special Issue on Glioma Research
A Case of Sustained Objective Response of Recurrent/Progressive Diffuse Intrinsic Pontine Glioma with Phenylbutyrate and Targeted Agents (Articles)

Stanislaw R. Burzynski, Gregory S. Burzynski, Sheldon Brookman

Journal of Cancer Therapy Vol.6 No.1, January 8, 2015

DOI: 10.4236/jct.2015.61006 3,778 Downloads 6,002 Views Citations
A Phase II Study of Antineoplastons A10 and AS2-1 in Children with Brain Tumors. Final Report (Protocol BT-10) (Articles)

Stanislaw R. Burzynski, Tomasz J. Janicki, Gregory S. Burzynski, Ania Marszalek

Journal of Cancer Therapy Vol.8 No.2, February 16, 2017

DOI: 10.4236/jct.2017.82015 1,739 Downloads 4,526 Views Citations
A Phase II Study of Antineoplastons A10 and AS2-1 in Adult Patients with Recurrent Glioblastoma Multiforme: Final Report (Protocol BT-21) (Articles)

Stanislaw R. Burzynski, Tomasz J. Janicki, Gregory S. Burzynski

Journal of Cancer Therapy Vol.5 No.10, September 10, 2014

DOI: 10.4236/jct.2014.510100 4,438 Downloads 6,838 Views Citations
This article belongs to the Special Issue on Glioma Research
Preliminary Findings on the Use of Targeted Therapy in Combination with Sodium Phenylbutyrate in Advanced Malignant Mesothelioma: A Strategy for Improved Survival (Articles)

Stanislaw R. Burzynski, Tomasz J. Janicki, Gregory S. Burzynski, Sheldon Brookman

Journal of Cancer Therapy Vol.5 No.12, October 29, 2014

DOI: 10.4236/jct.2014.512116 2,829 Downloads 4,415 Views Citations
A Phase II Study of Antineoplastons A10 and AS2-1 in Patients with Brainstem Gliomas. The Report on Non-Diffuse Intrinsic Pontine Glioma (Protocol BT-11) (Articles)

Stanislaw R. Burzynski, Tomasz J. Janicki, Gregory S. Burzynski, Ania Marszalek

Journal of Cancer Therapy Vol.6 No.4, April 13, 2015

DOI: 10.4236/jct.2015.64036 3,842 Downloads 6,495 Views Citations
A Phase II Study of Antineoplastons A10 and AS2-1 in Adult Patients with Primary Brain Tumors—Final Report (Protocol BT-09) (Articles)

Stanislaw R. Burzynski, Tomasz J. Janicki, Gregory S. Burzynski

Journal of Cancer Therapy Vol.6 No.12, November 25, 2015

DOI: 10.4236/jct.2015.612116 4,012 Downloads 6,994 Views Citations
Recurrent Glioblastoma Multiforme—A Strategy for Long-Term Survival (Articles)

Stanislaw R. Burzynski, Gregory S. Burzynski, Tomasz J. Janicki

Journal of Cancer Therapy Vol.5 No.10, September 10, 2014

DOI: 10.4236/jct.2014.510101 5,662 Downloads 9,086 Views Citations
This article belongs to the Special Issue on Glioma Research
A Phase II Study of Antineoplastons A10 and AS2-1 in Children with Recurrent, Refractory or Progressive Primary Brain Tumors—Final Report (Protocol BT-22) (Articles)

Stanislaw R. Burzynski, Tomasz J. Janicki, Gregory S. Burzynski, Ania Marszalek, Sheldon Brookman

Journal of Cancer Therapy Vol.5 No.10, September 10, 2014

DOI: 10.4236/jct.2014.510102 3,672 Downloads 5,349 Views Citations
This article belongs to the Special Issue on Glioma Research
A Phase II Study of Antineoplastons A10 and AS2-1 in Children with Low-Grade Astrocytomas—Final Report (Protocol BT-13) (Articles)

Stanislaw R. Burzynski, Tomasz J. Janicki, Gregory S. Burzynski

Journal of Cancer Therapy Vol.7 No.12, November 4, 2016

DOI: 10.4236/jct.2016.712083 1,616 Downloads 3,723 Views Citations
This article belongs to the Special Issue on Brain Tumor

	[email protected]
	+86 18163351462 (WhatsApp)
	1655362766
	SCIRP WeChat

All	Title	Abstract	Keywords
DOI	Author	Journal	Affiliation
ISSN	Subject

	[email protected]
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Browse Subjects

Publish with us

Home

About SCIRP

Service

Policies